188 related articles for article (PubMed ID: 31648773)
21. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
22. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
[TBL] [Abstract][Full Text] [Related]
23.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
24. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
[TBL] [Abstract][Full Text] [Related]
25. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
Persson J; Salehi S; Bollino M; Lönnerfors C; Falconer H; Geppert B
Eur J Cancer; 2019 Jul; 116():77-85. PubMed ID: 31181536
[TBL] [Abstract][Full Text] [Related]
26. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study.
Daraï E; Dubernard G; Bats AS; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Ballester M
Gynecol Oncol; 2015 Jan; 136(1):54-9. PubMed ID: 25450151
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
Bodurtha Smith AJ; Fader AN; Tanner EJ
Am J Obstet Gynecol; 2017 May; 216(5):459-476.e10. PubMed ID: 27871836
[TBL] [Abstract][Full Text] [Related]
28. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
[TBL] [Abstract][Full Text] [Related]
30. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.
Ianieri MM; Puppo A; Novelli A; Campolo F; Staniscia T; Di Martino G; Piovano E; Bruni F; Roviglione G; Mautone D; Ceccaroni M
Gynecol Obstet Invest; 2019; 84(4):383-389. PubMed ID: 30661071
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the treatment algorithm for sentinel lymph node mapping in endometrial cancer.
Pijnenborg JMA; Reijnen C; Vergeldt TFM; Zusterzeel PLM
Semin Oncol; 2020; 47(2-3):138-143. PubMed ID: 32513418
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in the management of gynecologic cancer.
Cibula D; Oonk MH; Abu-Rustum NR
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):66-72. PubMed ID: 25502426
[TBL] [Abstract][Full Text] [Related]
33. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
[TBL] [Abstract][Full Text] [Related]
34. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
[TBL] [Abstract][Full Text] [Related]
35. [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art].
Balaya V; Guani B; Bonsang-Kitzis H; Deloménie M; Ngô C; Montero Macias R; Koual M; Nguyen-Xuan HT; Bats AS; Mathevet P; Lécuru F
Bull Cancer; 2020 Jun; 107(6):696-706. PubMed ID: 31627905
[TBL] [Abstract][Full Text] [Related]
36. Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer.
Demirayak G; Comba C; Özdemir İA
J Minim Invasive Gynecol; 2018; 25(5):776. PubMed ID: 29146390
[TBL] [Abstract][Full Text] [Related]
37. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
Holloway RW; Bravo RA; Rakowski JA; James JA; Jeppson CN; Ingersoll SB; Ahmad S
Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
[TBL] [Abstract][Full Text] [Related]
38. [Sentinel lymph node identification using hysteroscopy in patients with endometrial cancer].
Feranec R; Mouková L; Stanícek J; Stefániková L; Chovanec J
Klin Onkol; 2010; 23(2):92-8. PubMed ID: 20465087
[TBL] [Abstract][Full Text] [Related]
39. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging.
Casarin J; Multinu F; Pasupathy K; Weaver A; McGree M; Tortorella L; Torres D; Kumar A; Langstraat C; Huang Y; Ghezzi F; Mariani A; Glaser G
Ann Surg Oncol; 2018 Nov; 25(12):3692-3698. PubMed ID: 30116949
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
Tortorella L; Casarin J; Multinu F; Cappuccio S; McGree ME; Weaver AL; Langstraat CL; Keeney GL; Kumar A; Melis GB; Angioni S; Scambia G; Mariani A; Glaser GE
Gynecol Oncol; 2019 Oct; 155(1):34-38. PubMed ID: 31402166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
